Multiple Myeloma

20112,298 citationsReview

Authors

Kenneth C. Anderson · Harvard University

Abstract

Autologous stem-cell transplantation and agents such as thalidomide, lenalidomide, and bortezomib have changed the management of myeloma and extended overall survival. This review discusses both the biologic features and the management of multiple myeloma.

Topics & Keywords

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Histone Deacetylase Inhibitors Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 364, Issue 11, pp. 1046-1060

DOI: 10.1056/nejmra1011442

Field-Weighted Citation Impact: 68.36